Rosuvastatin is NOT Prescribed for Hypertension Treatment
Rosuvastatin is a lipid-lowering medication (statin) used to reduce cardiovascular risk through cholesterol reduction, not to treat hypertension itself. While it may be prescribed alongside antihypertensive medications in patients who have both hypertension and dyslipidemia, it is not an antihypertensive drug 1.
Why Rosuvastatin May Be Prescribed in Hypertensive Patients
Cardiovascular Risk Reduction
Statins, including rosuvastatin, are recommended for hypertensive patients based on their overall cardiovascular risk profile, not for blood pressure control:
- Primary prevention: Statins are recommended for hypertensive patients aged 40-75 years with ≥10% 10-year cardiovascular disease risk and one or more CVD risk factors (dyslipidemia, diabetes, smoking) 2
- British guidelines: Recommend statin therapy for hypertensive patients with three or more cardiovascular risk factors (male sex, age ≥55 years, left ventricular hypertrophy, diabetes, smoking, etc.) or with established atherosclerotic disease 3, 4
- Canadian guidelines: Recommend statins for hypertensive patients with three or more cardiovascular risk factors or established atherosclerotic disease 5, 4
The Blood Pressure Question
The evidence on statins lowering blood pressure is mixed and clinically insignificant:
- Recent meta-analyses show rosuvastatin may produce a modest reduction in diastolic blood pressure (-2.12 mmHg) but no significant effect on systolic blood pressure 6, 7
- Another meta-analysis found statins did not significantly modulate blood pressure in hypertensive patients overall 7
- These small reductions are not clinically meaningful for hypertension management and do not justify using rosuvastatin as an antihypertensive agent
First-Line Hypertension Treatment
The 2024 ESC Guidelines clearly define first-line antihypertensive medications 1:
- ACE inhibitors
- Angiotensin receptor blockers (ARBs)
- Dihydropyridine calcium channel blockers
- Thiazide/thiazide-like diuretics
Rosuvastatin is conspicuously absent from this list.
Clinical Pitfalls to Avoid
- Do not prescribe rosuvastatin expecting blood pressure reduction - any BP-lowering effect is minimal and inconsistent
- Do not delay appropriate antihypertensive therapy by substituting or relying on statin therapy
- Do prescribe rosuvastatin in hypertensive patients when indicated for cardiovascular risk reduction based on lipid levels and overall CVD risk, not for BP control
- Fixed-dose combinations of rosuvastatin with actual antihypertensives (e.g., rosuvastatin/amlodipine) exist for patients with both conditions, but the rosuvastatin component addresses dyslipidemia, not hypertension 8, 9
The Bottom Line
Rosuvastatin treats dyslipidemia to reduce cardiovascular events. Hypertension requires dedicated antihypertensive medications. When both conditions coexist—which is common—both medication classes are prescribed together, each targeting its specific condition 3, 4, 2.